Global Bile Duct Cancer Drug Market Value to cross 268.0 MN by 2025
Posted On November 11, 2019
A report has recently been published on the Global Bile Duct Cancer Market by the well-known market research company, Value Market Research. The report states that the global bile duct cancer drug market is estimated to reach USD 268.0 MN by 2025 with a CAGR of 6.25% from 2019 to 2025. The main factors driving the growth of this market are the rise in the number of bile duct cancer patients worldwide, the technological innovation in terms of treatments and the increase in expenditure in the healthcare sector. Besides, the rise in research and development by the pharmaceutical companies and the rise in initiatives towards the treatment for bile duct cancer are also factors that are driving the growth of the bile duct cancer drug market . The global bile duct cancer drug market is anticipated to have a negative growth impact due to high cost and issues related to the approval of drugs.
Bile duct cancer is also termed as cholangiocarcinoma. It is a type of rare neoplasm. The method involves the alteration of epithelial cells that have originated in the bile ducts. A bile duct is a network of the tube that connects the liver to the gall bladder and it is intended to carry a fluid called bile which is secreted in the liver and stored in the gall bladder. The primary function of bile is to breakdown fats during the process of digestion. The commonly observed symptoms of bile duct cancer are abdominal pain, weight loss, abnormal functioning of the liver and discolouration of stool and urine. The only curative treatment for bile duct cancer is a surgery followed by the usage of chemotherapeutic drugs.
The report "Global Bile Duct Cancer Drug Market Report By Application (Hospitals, Clinics, And Others), Product (5-Fluorouracil, Gemcitabine, Cisplatin, Capecitabine, Oxaliplatin, And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2018-2025" covers the global bile duct cancer drug market by application, product, region and key players along with the estimated growth in opportunities and market value for the forecasted period.
By application, the global bile duct cancer drug market is segmented into hospitals and clinics out of which hospitals have been observed to be the leading segment as per the report. On the basis of product, the global bile duct cancer drug market is segmented into 5-fluorouracil, Gemcitabine, Cisplatin, Capecitabine and Oxaliplatin where 5-fluorouracil has emerged to be the leading segment.
North America, Europe, Asia-Pacific, Latin America and Middle East & Africa are the regions over which the bile duct cancer drug market is analysed over globally and North America is the region with the highest grossing bile cancer drug market.
The Report Segments Global Bile Duct Cancer Drug Market –
Middle East & Africa
Players Profiled In the Report:
Accord Healthcare Inc., Bristol-Myers Squibb Company, Celgene Corporation, Delcath Systems Inc., Eli Lilly and Company, F. Hoffman-La Roche AG, Fresenius Kabi AG, Intercept Pharmaceuticals Inc., Mylan N.V., Pfizer Inc. and Teva Pharmaceuticals Industries Ltd. among others. A detailed description which includes future capacities, key mergers & acquisitions, financial overview, collaborations and new product launches and developments are provided in the report with respect to the competitive landscape.
Download the FREE SAMPLE of Global Bile Duct Cancer Drug Market Research Report
About Value Market Research -
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.
We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Email: [email protected]